AtriCure, Inc. (NASDAQ: ATRC)
$30.8400
+0.7900 ( +2.80% ) 246.3K
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
Market Data
Open
$30.8400
Previous close
$30.0500
Volume
246.3K
Market cap
$1.48B
Day range
$29.8700 - $30.8400
52 week range
$18.9400 - $39.0450
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
pre | Proxies and info statements | 21 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |
4 | Insider transactions | 1 | Mar 14, 2024 |
4 | Insider transactions | 1 | Mar 07, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |